221
Participants
Start Date
May 26, 2015
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Bypassing Agents
Episodic or prophylactic treatment with the use of bypassing agents must be documented for at least the last 6 months prior to the study. During the study, treatment for bleeds will be documented. The choice of coagulation product is at the discretion of the investigator according to local practice standards in this non-interventional study and there are no specific protocol-defined interventions.
FVIII Replacement
Episodic or prophylactic treatment with the use of FVIII replacement must be documented for at least the last 6 months prior to the study. During the study, treatment for bleeds will be documented. The choice of coagulation product is at the discretion of the investigator according to local practice standards in this non-interventional study and there are no specific protocol-defined interventions.
National Taiwan Uni Hospital, Taipei
ICIC, San José
Royal Prince Alfred Hospital; Haematology, Camperdown
Charlotte Maxeke Johannesburg Hospital; Haemophilia Comprehensive Care Center, Johannesburg
The Alfred Hospital, Melbourne; Thrombosis and Haemostasis Unit, Melbourne
Cornell Univ Medical College; Hematology-Oncolog, New York
University of Pittsburgh, Pittsburgh
Georgetown Uni Medical Center; Lombardi Cancer Center, Washington D.C.
"IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi Angelo Bianchi e Bonomi", Milan
Hospital Universitario la Paz; Servicio de Hematologia, Madrid
Winship Cancer Institute, Atlanta
Hospital Universitario Virgen del Rocio; Servicio de Hematologia, Seville
Hospital Universitario la Fe; Servicio de Hematologia, Valencia
Children's Hospital of Michigan; Pediatrics, Detroit
AOU Careggi; SOD Malattie Emorragiche, Florence
Universitätsklinikum Bonn (AöR); Inst. für Experimentelle Hämatologie u. Transfusionsmedizin (IHT), Bonn
University of Colorado Denver, Children's Hospital, Aurora
Santa Monica Oncology Center, Santa Monica
Oregon Health & Science Uni ; Dept of Pediatrics, Portland
Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia, Seattle
Peking Union Medical College Hospital, Beijing
Tianjin Institute of Hematology & Blood Diseases Hospital, Tianjin
Nanfang Hospital, Southern Medical University, Guangzhou
Tulane Uni Health Sciences Center, New Orleans
Nagoya University Hospital, Aichi
Hyogo College of Medicine Hospital, Hyōgo
St. Marianna University School of Medicine Hospital, Kanagawa
Hospital of the University of Occupational and Environmental Health,Japan, Kitakyushu-shi
Nara Medical University Hospital, Nara
Tokyo Medical University Hospital, Tokyo
Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii, Gdansk
SPSK Nr1 Klinika Hematoo&Transpl.Szpiku, Lublin
ALVAMED Lekarskie Gabinety Specjalistyczne, Poznan
Instytut Hematologii i Transfuzjologii; Klinika Zaburzeń Hemostazy i Chorób Wewnętrznych, Warsaw
Severance Hospital, Seoul
Hoffmann-La Roche
INDUSTRY